Thursday, Jan 15, 2026 · SEC filings
What the smart money revealed on Jan 15
295 insider filings came in. We hid 59 planned (10b5-1) sellers and 168 people whose filings were routine, like grants and tax withholding.
Micron Technology (MU) Director Teyin Liu bought $7.82M
23,200 shares on the open market. Not a grant or an option exercise.
Surrozen (SRZN) Director Tim Kutzkey bought $357K
17,993 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.
Cosmos Health (COSM) CEO Grigorios Siokas bought $222K
493,495 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 7 checked quarters beat the typical stock 6 months later.
Greenwich LifeSciences (GLSI) CEO and CFO Snehal Patel bought $53.7K
1,800 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 9 checked quarters beat the typical stock 6 months later.
Jabil (JBL) Executive Chairman Mark Mondello sold $5.52M
Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 1.13M shares.
Olema Pharmaceuticals (OLMA) CH. Operating & Financial OFF. Shane Kovacs sold $2.98M
Not marked as a planned 10b5-1 sale. Sold 43% of the shares they held directly. Still holds 139,727 shares.
Salesforce (CRM) Director Neelie Kroes sold $929K
Not marked as a planned 10b5-1 sale. Sold 35% of the shares they held directly. Still holds 7,299 shares.
Show 11 more real buys
Show 29 more real sales
13F season
Holdings as of Dec 31, 2025 are due Feb 17
320 funds have filed so far. 81 filed for the quarter before.
Biggest real insider buys this week
Open-market buys by officers and directors, filed in the 7 days up to Jan 15.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.